106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2022 All rights reserved
ACRKAW02223a
Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should
not be considered exclusive of other methods of care reasonably directed at obtaining the same
results. e ultimate judgment concerning the propriety of any course of conduct must be made by
the clinician aer consideration of each individual patient situation. Neither IGC, the American
College of Rheumatology, nor the authors endorse any product or service associated with the
distributor of this clinical reference tool.
Abbreviations
ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; GC, glucocorticoids;
IVIG, intravenous immunoglobulin; KD, Kawasaki disease; NSAID, non-steroidal anti-
inflammatory drugs; UA, urinalysis; WBC, white blood cell
Source
Gorelik M, Chung SA, Ardalan K, et al. 2021 American College of Rheumatolog y/Vasculitis
Foundation Guideline for the Management of Kawasaki Disease. Arthritis & Rheumatolog y,
2022 Mar 8. doi: 10.1002/art.42041. Epub ahead of print.
